Document is current
Any future updates will be listed below
-
Authors
Santos, Tânia https://orcid.org/0000-0001-7528-6902
Pires-Luís, Ana S. https://orcid.org/0000-0001-5067-903X
Calado, Ana Margarida https://orcid.org/0000-0002-1962-8928
Oliveira, Elsa https://orcid.org/0000-0002-8482-5047
Cunha, Mariana https://orcid.org/0000-0001-9136-6400
Silva, Joaquina https://orcid.org/0000-0002-3799-3232
Viana, Paulo https://orcid.org/0000-0002-0703-7119
Teixeira-da-Silva, José
Oliveira, Cristiano
Barros, Alberto https://orcid.org/0000-0002-8700-3698
Sá, Rosália https://orcid.org/0000-0002-6551-3822
Sousa, Mário https://orcid.org/0000-0002-3009-3290
- License Information
-
More Information
Article History
Received: 6 May 2024
Accepted: 17 October 2024
First Online: 28 October 2024
Declarations
:
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: According to the determinations of the National Law of Medically Assisted Procreation (Law of 2017) and guidelines of the National Council for Medically Assisted Procreation (CNPMA-2021), the use of clinical databases and patients’ biological material for diagnosis and research may be used without additional ethical approval, as long as research is used under strict individual anonymity and after informed and written consent from the patient. The use of human oocytes in laboratory experimentation (processing for microscopy) was authorized by the Ethics Committee ICBAS/CHUP with project number: 2019/CE/P017 (266/CETI/ ICBAS). The authors declare that they have followed all the rules of ethical conduct regarding originality, data processing and analysis, duplicate publication and biological material.
